- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02939105
CoolSculpting Treatment in the Upper Arms (ARM)
DualSculpting the Upper Arms Using Vacuum Applicators and a Customized Treatment Approach
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V6E 4M3
- Pacific Dermaesthetics
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria
- Male or female subjects > 22 years of age and < 65 years of age.
- Subject has clearly visible fat sufficient for treatment on the upper arm, which in the investigator's opinion, may benefit from the treatment.
- No weight change exceeding 5% in the preceding month.
- Subject agrees to maintain his/her weight (i.e., within 5% of total body weight) by not making any major changes in their diet or exercise routine during the course of the study.
- Subject has read and signed the study written informed consent form.
Exclusion Criteria
- History of a fat reduction procedure (e.g., liposuction, surgery, lipolytic agents, etc.), or implants in or adjacent to the area of intended treatment.
- History of prior surgery in the arms.
- Known history of cryoglobulinemia, cold urticaria, cold agglutinin disease, or paroxysmal cold hemoglobinuria.
- Known history of Raynaud's disease, or any known condition with a response to cold exposure that limits blood flow to the skin.
- History of bleeding disorder or is taking any medication that in the investigator's opinion may increase the subject's risk of bruising.
- History of carpal tunnel syndrome, compartment syndrome or deep vein thrombosis in the upper extremities.
- Currently taking or has taken diet pills or weight control supplements within the past month.
- Any dermatological conditions, such as scars, infection, in the location of the treatment area that may interfere with the treatment or evaluation.
- Active implanted device such as a pacemaker, defibrillator, or drug delivery system.
- Pregnant or intending to become pregnant in the next 5 months.
- Lactating or has been lactating in the past 6 months.
- Unable or unwilling to comply with the study requirements.
- Currently enrolled in a clinical study of any other unapproved investigational drug or device. Any other condition or laboratory value that would, in the professional opinion of the investigator, potentially affect the subject's response or the integrity of the data or would pose an unacceptable risk to the subject.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: CoolSculpting Treatment in the Upper Arm
Subjects in the study were treated with the CoolSculpting System with one of two vacuum applicator types for bilateral fat reduction in the upper arms. Applicators were used concurrently, with an applicator on each arm. Each subject received 1 or 2 cooling cycles on each arm for 35 minutes at protocol-defined temperatures. The Investigator selected the applicator for each subject based on the intended fat volume of the treatment area. |
The CoolSculpting device will be used to perform treatments.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Proportion of Correctly Identified Pre-treatment Photos
Time Frame: 12 weeks post-final treatment
|
Change in the treated vs. untreated areas will be assessed by observation of changes in surface contour and/or fat volume by an independent photo review of pre-treatment and post-treatment images.
Reviewers are practicing dermatologists or plastic surgeons.
All reviewers will be blinded to post-treatment vs. baseline untreated area.
The order in which images are presented will be randomized; for each subject placement of the baseline, pre-treatment image will be randomized for each pair of subject images.
Reviewers will be asked to select the baseline photos for each subject photo series and record selections on a data collection form.
Criteria for evaluable photos for the purposes of the independent review: subject completed treatment regimen; subject has complete set of baseline photos; subject has a complete set of post-treatment photos; photos were taken using Zeltiq standard procedure.
The expected success rate is 70% correct identification by 2 out of 3 reviewers.
|
12 weeks post-final treatment
|
Number of Participants With Unanticipated Adverse Device Effects (UADE) Associated With the CoolSculpting System and Vacuum Applicators in the Upper Arms
Time Frame: Enrollment through12 weeks post-final treatment
|
The primary safety endpoint of the study is the incidence of unanticipated adverse device effects (UADE) reported in the study period.
Investigators assessed each adverse event to determine if there was relationship to the study device or procedure.
Adverse event data are collected from the time of study enrollment through the final follow-up visit at 12 weeks post-treatment.
|
Enrollment through12 weeks post-final treatment
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jason Rivers, MD, Pacific Dermaesthetics
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ZA16-005
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Body Fat Disorder
-
Zeltiq AestheticsCompleted
-
Zeltiq AestheticsCompleted
-
Zeltiq AestheticsCompleted
-
Zeltiq AestheticsCompletedBody Fat DisorderUnited States
-
Zeltiq AestheticsCompleted
-
Zeltiq AestheticsCompleted
-
Zeltiq AestheticsCompleted
Clinical Trials on The ZELTIQ CoolSculpting System
-
Zeltiq AestheticsCompleted
-
Zeltiq AestheticsCompleted
-
Zeltiq AestheticsCompleted
-
Zeltiq AestheticsCompleted
-
Zeltiq AestheticsCompleted
-
Zeltiq AestheticsCompletedBody Fat DisorderUnited States, Canada
-
Dermatology, Laser & Vein Specialists of the CarolinasUnknownGynecomastiaUnited States
-
Massachusetts General HospitalCompletedAdiposityUnited States
-
Zeltiq AestheticsActive, not recruiting